Chronic migraine sufferers taking GLP-1 drugs were about 10% less likely to need ER care for a migraine attack compared to those taking a standard first-line migraine drug, researchers are scheduled to report at an upcoming meeting of the American Academy of Neurology in Chicago
By 2030, we expect the market size to exceed $100 billion in the U.S. It is estimated that by then, 1 in 10 Americans will be on a GLP-1 medication
However, this is not usually recommended in certain patients, such as cancer patients, those who have had radiation therapy on their bones, or those with active bone metastasis, since they have a higher risk of developing or advancing bone malignancies
How Long Does Retatrutide Take to Kick In
Regarding the secondary endpoint of the proportion of patients achieving 20% body weight reduction within the study, there was a dose-dependent group size of 50% of the participants receiving the dose of 10 mg tirzepatide and a proportion of 57% in the study arm with 15 mg